Evidence map›Paper›PMID 19376221›Full record

ArticleFree radical biology & medicine2009

Lipid-derived free radical production in superantigen-induced interstitial pneumonia.

Hisako Miyakawa, Ronald P Mason, Jinjie Jiang, Maria B Kadiiska

Abstract read
In one paragraph

Article in Free radical biology & medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Hisako MiyakawaFree Radical Metabolite Section, Laboratory of Pharmacology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
Ronald P Mason
Jinjie Jiang
Maria B Kadiiska
National Institutes of Health · USNational Institute of Environmental Health Sciences · US

Funding

In Vivo Detection of Free Radical GenerationZIAES050117 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI MASON, RONALD P · 2009 to 2018
$6.9M
TRANSITION-METAL MEDIATED FREE RADICAL FORMATION IN VITRO AND IN VIVOZ01ES050117 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI MASON, RONALD P · 1991 to 2008
$2.2M
Intramural NIH HHS Z01 ES050117Intramural NIH HHS Z99 ES999999
6 · The paper itself

Abstract

We studied the free radical generation involved in the development of interstitial pneumonia (IP) in an animal model of autoimmune disease. We observed an electron spin resonance (ESR) spectrum of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone (POBN) radical adducts detected in the lipid extract of lungs in autoimmune-prone mice after intratracheal instillation of staphylococcal enterotoxin B. The POBN adducts detected by ESR were paralleled by infiltration of macrophages and neutrophils into the bronchoalveolar lavage fluid. To further investigate the mechanism of free radical generation, mice were pretreated with the macrophage toxicant gadolinium chloride, which significantly suppressed the radical generation. Free radical generation was also decreased by pretreatment with the xanthine oxidase (XO) inhibitor allopurinol, the iron chelator Desferal, and the inducible nitric oxide synthase (iNOS) inhibitor 1400W. Histopathologically, these drugs significantly reduced both the cell infiltration into the alveolar septal walls and the synthesis of pulmonary collagen fibers. Experiments with NADPH oxidase knockout mice showed that NADPH oxidase did not contribute to lipid radical generation. These results suggest that lipid-derived carbon-centered free radical production is important in the manifestation of IP and that a macrophage toxicant, an XO inhibitor, an iron chelator, and an iNOS inhibitor protect against both radical generation and the manifestation of IP.

Indexed as

AllopurinolAmidinesAnimalsAnti-Inflammatory AgentsBenzylaminesCell MovementDeferoxamineElectron Spin Resonance SpectroscopyEnterotoxinsFemaleGadoliniumIron Chelating AgentsLungLung Diseases, InterstitialMacrophagesMembrane GlycoproteinsAllopurinolAmidinesAnti-Inflammatory AgentsBenzylaminesCybb protein, mouseDeferoxamineenterotoxin B, staphylococcalEnterotoxinsGadoliniumgadolinium chlorideIron Chelating AgentsMembrane GlycoproteinsN-(3-(aminomethyl)benzyl)acetamidineNADPH Oxidase 2NADPH OxidasesNitric Oxide SynthasePyridines(pyridyl-4-N-oxide)-N-tert-butylnitroneSuperantigensXanthine Oxidase

Identifiers

PMID19376221
PMCPMC2700201
OpenAlexW2002642759

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.